Cargando…

Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability

The detrimental effect of hyperglycemia and glucose variability (GV) on target organs in diabetes can be implemented through a wide network of regulatory peptides. In this study, we assessed a broad panel of serum cytokines and growth factors in subjects with type 1 diabetes (T1D) and estimated asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klimontov, Vadim V., Mavlianova, Kamilla R., Orlov, Nikolai B., Semenova, Julia F., Korbut, Anton I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603953/ https://www.ncbi.nlm.nih.gov/pubmed/37893217 http://dx.doi.org/10.3390/biomedicines11102843

Ejemplares similares

Glucose Variability: How Does It Work?
por: Klimontov, Vadim V., et al.
Publicado: (2021)

Multiplex Bead Array Assay of a Panel of Circulating Cytokines and Growth Factors in Patients with Albuminuric and Non-Albuminuric Diabetic Kidney Disease
por: Klimontov, Vadim V., et al.
Publicado: (2020)

Continuous Glucose Monitoring in Patients Following Simultaneous Pancreas–Kidney Transplantation: Time in Range and Glucose Variability
por: Dmitriev, Ilya V., et al.
Publicado: (2023)

Carotid Artery Disease in Subjects with Type 2 Diabetes: Risk Factors and Biomarkers
por: Klimontov, Vadim V., et al.
Publicado: (2021)

Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density
por: Fazullina, Olga N, et al.
Publicado: (2022)

Urinary Markers of Tubular Injury and Renal Fibrosis in Patients with Type 2 Diabetes and Different Phenotypes of Chronic Kidney Disease
por: Korbut, Anton I., et al.
Publicado: (2023)

Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
por: Klimontov, Vadim V, et al.
Publicado: (2020)

Nocturnal Glucose Patterns with and without Hypoglycemia in People with Type 1 Diabetes Managed with Multiple Daily Insulin Injections
por: Kladov, Danil E., et al.
Publicado: (2023)

Bioinformatic Reconstruction and Analysis of Gene Networks Related to Glucose Variability in Diabetes and Its Complications
por: Saik, Olga V., et al.
Publicado: (2020)

Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes
por: Korbut, Anton I, et al.
Publicado: (2019)

Heart rate variability is associated with interstitial glucose fluctuations in type 2 diabetic women treated with insulin
por: Klimontov, Vadim V., et al.
Publicado: (2016)

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
por: Korbut, Anton I., et al.
Publicado: (2020)

Machine Learning Models for Nocturnal Hypoglycemia Prediction in Hospitalized Patients with Type 1 Diabetes
por: Berikov, Vladimir B., et al.
Publicado: (2022)

Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring
por: Zhou, Jian, et al.
Publicado: (2011)

Medical genomics research at BGRS-2018
por: Baranova, Ancha V., et al.
Publicado: (2019)

Medical Genetics, Genomics and Bioinformatics Aid in Understanding Molecular Mechanisms of Human Diseases
por: Orlov, Yuriy L., et al.
Publicado: (2021)

Cytokine Levels in the Serum of Healthy Subjects
por: Kleiner, Giulio, et al.
Publicado: (2013)

Medical Genetics, Genomics and Bioinformatics—2022
por: Klimontov, Vadim V., et al.
Publicado: (2023)

Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks
por: Saik, Olga V., et al.
Publicado: (2021)

Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?
por: Saik, Olga V., et al.
Publicado: (2022)

Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study
por: Foreman, Yuri D., et al.
Publicado: (2021)

Effect of exercise on glucose variability in healthy subjects: randomized crossover trial
por: Figueira, Franciele Ramos, et al.
Publicado: (2019)

A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis
por: Bhargava, Ramya, et al.
Publicado: (2019)

P1072: SIGNIFICANT PREDICTORS OF DECREASED BONE MINERAL DENSITY IN PATIENTS WITH HODGKIN’S LYMPHOMA
por: Voytko, Mariya, et al.
Publicado: (2023)

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
por: Fang, Qichen, et al.
Publicado: (2013)

Serum glucose variability and brain-serum glucose ratio predict metabolic distress and mortality after severe brain injury
por: Kurtz, P, et al.
Publicado: (2009)

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes
por: Hanefeld, Markolf, et al.
Publicado: (2017)

Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
por: Han, Eugene, et al.
Publicado: (2020)

Variation of glucose time in range in type 1 diabetes
por: Hansen, Klavs Würgler, et al.
Publicado: (2022)

Baseline Levels and Temporal Stability of 27 Multiplexed Serum Cytokine Concentrations in Healthy Subjects
por: Biancotto, Angelique, et al.
Publicado: (2013)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
por: Fassio, Angelo, et al.
Publicado: (2022)

Glycemic variability in relation to oral disposition index in the subjects with different stages of glucose tolerance
por: Chen, Tong, et al.
Publicado: (2013)

Are Soluble ST2 Levels in the Picogram or Nanogram Range in Serum of Healthy Subjects/Disease Patients?
por: Saluja, Rohit
Publicado: (2014)

Range of glucose as a glycemic variability and 3–month outcome in diabetic patients with acute ischemic stroke
por: Kim, Young Seo, et al.
Publicado: (2017)

Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients
por: Ormstad, Heidi, et al.
Publicado: (2011)

Glucose Variability
por: Service, F. John
Publicado: (2013)

Correction: Baseline Levels and Temporal Stability of 27 Multiplexed Serum Cytokine Concentrations in Healthy Subjects
por: Biancotto, Angelique, et al.
Publicado: (2015)

Serum profile of cytokines and their genetic variants in metabolic syndrome and healthy subjects: a comparative study
por: Zafar, Uzma, et al.
Publicado: (2019)

Ranges of phenotypic flexibility in healthy subjects
por: van den Broek, T. J., et al.
Publicado: (2017)

Meaning of upper limit of normal range of post‐load 1‐h plasma glucose level defined by oral glucose tolerance test in Japanese subjects
por: Iwao, Tadashi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1qpbfd4vjb2s69806umvctn5jt